Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

6.35
Delayed Data
As of Feb 05
 -0.47 / -6.89%
Today’s Change
6.15
Today|||52-Week Range
30.13
-36.88%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close6.82
Today’s open6.81
Day’s range6.25 - 6.94
Volume755,783
Average volume (3 months)1,068,418
Market cap$214.4M
Dividend yield--
Data as of 02/05/2016

Growth & Valuation

Earnings growth (last year)-73.20%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book1.84

Competitors

 Today’s
change
Today’s
% change
CARACara Therapeutics In...-0.82-9.43%
IDRAIdera Pharmaceutical...-0.06-3.16%
ZGNXZogenix Inc-0.41-4.61%
EGLTEgalet Corp-0.06-0.68%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 11, 2016
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$0.00
Annual profit (last year)-$47.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. O'Connor
COO, Secretary, EVP &
Head-Investor Relations
Gregory T. Mayes
Corporate headquarters
Princeton, New Jersey

Forecasts

Partner Offers